跳到正文
原文
Nature 健康护理主题·· 2026-10-18AI 评分49

英国 6250 万人研究:406 种罕见病患病率与 COVID-19 感染率随族裔而异

Prevalence of 406 rare diseases by ethnicity and recorded COVID-19 infection rates among 62.5 million people in England

AI 导读

英国一项覆盖 6250 万人的研究显示,约 105 万人(1.7%)患有 406 种罕见病中的至少一种。罕见病群体记录的 COVID-19 感染率为 32.8%,高于非罕见病群体的 29.0%,且各族裔间存在差异。按更细的族裔分类分析时,罕见病患病率差异显著,宽泛分类可能掩盖这些差异。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Rare diseases (RD) are individually uncommon but collectively affect millions of people. Yet national estimates of their prevalence, especially across ethnic groups, are limited, and how the COVID-19 pandemic affected people with RD across ethnic groups is unknown. We aimed to estimate the prevalence of 406 RD by ethnicity, and to describe recorded COVID-19 infection across these RD and ethnic groups, in England. We conducted a cross-sectional study within the National Health Service (NHS) England Secure Data Environment, accessed via the British Heart Foundation (BHF) Data Science Centre’s CVD-COVID-UK/COVID-IMPACT Consortium, linking primary care, hospital, and mortality records for individuals alive on 31 July 2023. We calculated age- and sex-standardised prevalence for 406 RD, and recorded COVID-19 infection rates for the overall group, for each RD, and across the six-group Office for National Statistics (ONS) and 19-group NHS ethnicity classifications. Of 62.5 million people, 1.05 million (1.7%) had at least one of the 406 RD. Recorded COVID-19 infection was higher in the RD group than in the non-RD population (32.8% vs. 29.0%). Within the RD group, infection rates varied by ethnicity (e.g. 27.7% in the Pakistani and 23.8% in the Black African groups, versus 33.7% in the White British group) and by specific RD (24.6–41.2% among the 25 most common). Age- and sex-standardised prevalence also varied widely across ethnic groups, with substantial heterogeneity emerging only when broad categories were disaggregated into the more granular NHS classifications (for example, markedly elevated discoid lupus erythematosus prevalence in Black Caribbean but not Black African individuals, obscured within the aggregate “Black” category). This national, ethnicity-resolved map shows that rare-disease prevalence varies substantially across ethnic groups, with differences largely hidden within broad categories, and that recorded COVID-19 infection among people with RD varied across ethnic groups, with the highest rates observed in the ONS White and NHS White British groups. These findings provide a baseline to support earlier, fairer diagnosis and more targeted care.

Abbreviations

BHF:

British Heart Foundation

CHESS:

COVID-19 Hospitalisations in England surveillance system

CI:

Confidence interval

CVD:

Cardiovascular disease

EHR:

Electronic health record

GDPPR:

General practice extraction service data for pandemic planning and research

GPES:

General practice extraction service

HES-APC:

Hospital episode statistics admitted patient care

HES-OPC:

Hospital episode statistics outpatient care

ICD-10:

International classification of diseases, tenth revision

IMD:

Index of multiple deprivation

LFD:

Lateral flow device

NHS:

National Health Service

ONS:

Office for national statistics

OR:

Odds ratio

PCR:

Polymerase chain reaction

RD:

Rare disease

SDE:

Secure data environment

SGSS:

Second generation surveillance system

SNOMED CT:

Systematised nomenclature of medicine clinical terms

Acknowledgements

This work was carried out with the support of the BHF Data Science Centre led by Health Data Research UK (BHF Grant no. SP/19/3/34678). This study made use of anonymised data held in NHS England’s Secure Data Environment service for England and made available via the BHF Data Science Centre’s CVD-COVID-UK/COVID-IMPACT consortium. This work used data provided by patients and collected by the NHS as part of their care and support. We would also like to acknowledge all data providers who make health relevant data available for research. The BHF Data Science Centre’s Health Data Science Team provided data curation resources and support. We also thank Huayu Zhang for his contributions to the foundational phenotyping workflows. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). The Alan Turing Institute also supported this work via ‘Towards Turing 2.0’ EPSRC Grant Funding. The funders had no role in the study design, data collection, data analysis, data interpretation, or report writing.

Funding

The British Heart Foundation Data Science Centre (grant No SP/19/3/34678, awarded to Health Data Research (HDR) UK), funded co-development (with NHS England) of the Secure Data Environment service for England, provision of linked datasets, data access, user software licences, computational usage, data management and wrangling support, and part-funded the time of contributing data analysts, biostatisticians, epidemiologists, and clinicians, to coordinate national COVID-19 priority research.

Author information

Author notes

  1. A list of authors and their affiliations appears at the end of the paper.

Authors and Affiliations

  1. Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK

    Qingze Gu, Seyed Alireza Hasheminasab, Marta Pineda-Moncusí & Sara Khalid

  2. Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK

    Chimweta Chilala

  3. Institute of Health Informatics, University College London, London, UK

    Johan H. Thygesen & Honghan Wu

  4. British Heart Foundation Data Science Centre, Health Data Research UK, London, UK

    Amy Coombe

Authors

  1. Qingze Gu
  2. Seyed Alireza Hasheminasab
  3. Marta Pineda-Moncusí
  4. Chimweta Chilala
  5. Johan H. Thygesen
  6. Honghan Wu
  7. Sara Khalid

Consortia

CVD-COVID-UK/COVID-IMPACT Consortium

  • Amy Coombe

Corresponding author

Correspondence to Sara Khalid.

Ethics declarations

Competing interests

This work was supported by The Alan Turing Institute via ‘Towards Turing 2.0’ EPSRC Grant Funding. Amgen, Astellas, Janssen, Synapse Management Partners and UCB Biopharma have funded or supported training programmes organised by SK’s department. SK receives funding support from Amgen BioPharma outside of this work. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). The remaining authors have nothing to declare.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gu, Q., Hasheminasab, S.A., Pineda-Moncusí, M. et al. Prevalence of 406 rare diseases by ethnicity and recorded COVID-19 infection rates among 62.5 million people in England. Sci Rep (2026). https://doi.org/10.1038/s41598-026-70531-4

Download citation

  • Received: 19 January 2026

  • Accepted: 03 September 2026

  • Published: 18 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-70531-4

Keywords

来源:Nature 健康护理主题 · nature.com